OBJECTIVE: We investigated whether stromelysin, a candidate gene in atherogenesis, plays a role in atherogenesis of systemic lupus erythematosus (SLE), a leading cause of mortality in SLE. PATIENTS AND METHODS: A genetic study using polymorphism located in the promoter region of stromelysin was performed in 55 Italian patients with SLE. Carotid intimal-medial thickness (IMT) was evaluated by B mode ultrasonography. RESULTS: All patients with an "abnormal" (> or =0.9 mm) IMT carried at least one 6A allele, and the degree of IMT was significantly greater in patients carrying at least one 6A allele (0.63 +/- 0.22 vs 0.43 +/- 0.04 mm, 5A/6A + 6A/6A vs 5A/5A, p = 0.018). CONCLUSION: Our data show that polymorphism of stromelysin promoter may be relevant for SLE-related cardiovascular disease.
OBJECTIVE: We investigated whether stromelysin, a candidate gene in atherogenesis, plays a role in atherogenesis of systemic lupus erythematosus (SLE), a leading cause of mortality in SLE. PATIENTS AND METHODS: A genetic study using polymorphism located in the promoter region of stromelysin was performed in 55 Italian patients with SLE. Carotid intimal-medial thickness (IMT) was evaluated by B mode ultrasonography. RESULTS: All patients with an "abnormal" (> or =0.9 mm) IMT carried at least one 6A allele, and the degree of IMT was significantly greater in patients carrying at least one 6A allele (0.63 +/- 0.22 vs 0.43 +/- 0.04 mm, 5A/6A + 6A/6A vs 5A/5A, p = 0.018). CONCLUSION: Our data show that polymorphism of stromelysin promoter may be relevant for SLE-related cardiovascular disease.
Authors: James H Stein; Claudia E Korcarz; Maureen E Mays; Pamela S Douglas; Mari Palta; Hongling Zhang; Tamara Lecaire; Diane Paine; David Gustafson; Liexiang Fan Journal: J Am Soc Echocardiogr Date: 2005-03 Impact factor: 5.251
Authors: Dai Wang; Huiying Yang; Manuel J Quiñones; Isabel Bulnes-Enriquez; Xochitl Jimenez; Roxana De La Rosa; Tamara Modilevsky; Katherine Yu; Yanjie Li; Kent D Taylor; Willa A Hsueh; Howard N Hodis; Jerome I Rotter Journal: Stroke Date: 2005-02-03 Impact factor: 7.914
Authors: J M Esdaile; M Abrahamowicz; T Grodzicky; Y Li; C Panaritis; R du Berger; R Côte; S A Grover; P R Fortin; A E Clarke; J L Senécal Journal: Arthritis Rheum Date: 2001-10
Authors: Hiroyasu Uzui; Alice Harpf; Ming Liu; Terence M Doherty; Arun Shukla; Ning-Ning Chai; Pinky V Tripathi; Stefan Jovinge; Douglas J Wilkin; Kamlesh Asotra; Prediman K Shah; Tripathi B Rajavashisth Journal: Circulation Date: 2002-12-10 Impact factor: 29.690
Authors: Tanja Rundek; Mitchell S Elkind; John Pittman; Bernadette Boden-Albala; Steve Martin; Steve E Humphries; Suh-Hang Hank Juo; Ralph L Sacco Journal: Stroke Date: 2002-05 Impact factor: 7.914
Authors: Mary J Roman; Beth-Ann Shanker; Adrienne Davis; Michael D Lockshin; Lisa Sammaritano; Ronit Simantov; Mary K Crow; Joseph E Schwartz; Stephen A Paget; Richard B Devereux; Jane E Salmon Journal: N Engl J Med Date: 2003-12-18 Impact factor: 91.245
Authors: Faith Selzer; Kim Sutton-Tyrrell; Shirley G Fitzgerald; Joan E Pratt; Russell P Tracy; Lewis H Kuller; Susan Manzi Journal: Arthritis Rheum Date: 2004-01